Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input

Environment International

Volumn 35, Issue 2, 2009, Pages 363-368

  Letzel, Marion ^a   Metzner, Gerhard ^a   Letzel, Thomas ^b  

^a Bavarian Environmental Agency   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

ATV water quality model; Diclofenac; Exposure assessment; Mass flux; Pharmaceuticals; Sewage treatment plants; Surface water

Indexed keywords

DRUG PRODUCTS; FISHERIES; MASS TRANSFER; SEWAGE TREATMENT PLANTS; SURFACE WATERS; UNCERTAINTY ANALYSIS; WATER QUALITY; WATER TREATMENT;

AQUATIC ENVIRONMENTS; CONCENTRATION MEASUREMENT; DICLOFENAC; EXPOSURE ASSESSMENT; LONG-TERM MEASUREMENTS; PREDICTED ENVIRONMENTAL CONCENTRATIONS; PREDICTED NO-EFFECT CONCENTRATIONS; WATER QUALITY MODELING;

EFFLUENTS;

DICLOFENAC; SURFACE WATER;

CONCENTRATION (COMPOSITION); DRUG; FISH; FRESHWATER ENVIRONMENT; SEWAGE TREATMENT; SURFACE WATER; WATER QUALITY;

AQUATIC ENVIRONMENT; ARTICLE; CONTROLLED STUDY; EFFLUENT; ENVIRONMENTAL EXPOSURE; FISH; FLOW RATE; GERMANY; LONG TERM EXPOSURE; PREDICTION; PRIORITY JOURNAL; RIVER; SEWAGE TREATMENT PLANT; UNCERTAINTY; WATER QUALITY; WATER SAMPLING;

CENTRAL EUROPE; EURASIA; EUROPE; GERMANY; MAIN RIVER [GERMANY];

AMBYSTOMA TIGRINUM STEBBENSI VIRUS;

EID: 58349091020     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2008.09.002     Document Type: Article

References (48)

1. Andreozzi R., Raffaele M., and Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50 10 (2003) 1319-1330
2. Ashton D., Hilton M., and Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333 1-3 (2004) 167-184
3. Avdeef A., Berger C.M., and Brownell C. pH-metric solubility 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm. Res. 17 1 (2000) 85-89
4. Bleninger T., Hauschild I., Jirka G.H., Leonhard D., and Schlenkhoff A. Immissionsorientierte Bewertung von Einleitungen in Gewässer: Mischzonen oder Opferstrecken, wo gelten die Gütekriterien. Wasserwirtschaft 94 4 (2004) 40-44 (in German)
5. Buser H.-R., Poiger T., and Müller M.D. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 32 22 (1998) 3449-3455
6. Christoffels E. The ATV water quality model - a water management planning support tool - the example of the Erft River. KA - Wasserwirtschaft, Abwasser, Abfall 48 7 (2001) 968-972 (in German)
7. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142 3 (2003) 185-194
8. Deng A., Himmelsbach M., Zhu Q.Z., Frey S., Sengl M., Buchberger W., et al. Residue analysis of the pharmaceutical diclofenac in different water types using ELISA and GC-MS. Environ Sci Technol 37 15 (2003) 3422-3429
9. EC. Technical guidance document on risk assessment. TGD; part ii. Technical report, institute for health and consumer protection, European Chemicals Bureau, European Commission (EC) (2003)
10. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76 2 (2006) 122-159
11. Ferrari B., Paxéus N., Lo Giudice R., Pollio A., and Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid and diclofenac. Ecotoxicol Environ Saf 55 3 (2003) 359-370
12. Gómez M.J., Martínez Bueno M.J., Lacorte S., Fernández-Alba A.R., and Agüera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66 6 (2007) 993-1002
13. Gros M., Petrović M., and Barcelo D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River Basin (Northeast Spain). Environ Toxicol Chem 26 8 (2007) 1553-1562
14. Heberer T., and Feldmann D. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents - modeling versus measurements. J. Hazard. Mat. 122 3 (2005) 211-218
15. Heberer T., Schmidt-Bäumler K., and Stan H.-J. Occurrence and distribution of organic contaminants in aquatic system in Berlin. Part I: drug residues and other polar contaminants in Berlin surface and groundwater. Acta hydrochim hydrobiol 26 5 (1998) 272-278
16. Hoeger B., Köllner B., Dietrich D.R., and Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat Toxicol 75 1 (2005) 53-64
17. Hong H.N., Park K.S., Lee S.-K., and Gu M.B. Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR. Chemosphere 67 11 (2007) 2115-2121
18. Huschek G., and Krengel D. Mengenermittlung und Systematisierung von Arzneimittelwirkstoffen im Rahmen der Umweltprüfung von Human- und Tierarzneimittel gemäß § 28 AMG. Forschungsbericht 200 67 401 im Auftrag des Umweltbundesamts (2002) (in German)
19. Johnson R. Analysis of bentazon in river water. LC-GC Europe environmental - the application notebook - September 2006 (2006) 36
20. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., and Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39 14 (2005) 3139-3152
21. Jux U., Baginski R.M., Arnold H.-G., Krönke M., and Seng P.N. Detection of pharmaceutical contaminations of river, pond, and tap water from Cologne (Germany) and surroundings. Int J Hyg Environ Health 205 5 (2002) 393-398
22. Kimura K., Hara H., and Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and memrane bioreactors. Environ Sci Technol 41 10 (2007) 3708-3714
23. Knopp D., Deng A., Letzel M., Taggart M., Himmelsbach M., Zhu Q.-Z., et al. Immunological determination of the pharmaceutical diclofenac in environmental and biological samples. Rational environmental management of agrochemicals: risk assessment, monitoring and remedial action. ACS symposium series book vol. 966 (2007) 203-226
24. Koutsouba V., Heberer T., Fuhrmann B., Schmidt-Baumler K., Tsipi D., and Hiskia A. Determination of polar pharmaceuticals in sewage water of Greece by gas chromatography-mass spectrometry. Chemosphere 51 2 (2003) 69-75
25. Letzel M, Grosse S, Grill E, Letzel T. Disc extraction and LC-MS: analysis of acidic compounds in sewage plants and surfacewater. J Chromatrogr A in preparation.
26. Lindqvist N., Tuhkanen T., and Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res 39 11 (2005) 2219-2228
27. LUA Brandenburg. Ecotoxicological assessment of human pharmaceuticals in aquatic ecosystems. Eds: Landesumweltamt Brandenburg (LUA). Studien- und Tagungsberichte, 0948-0838 39 (2002) (in German)
28. Mersmann, P. (2003): Transport behaviour and sorption of the pharmaceutically substances carbamazepine, clofibric acid, diclofenac, ibuprofen and propyphenazone in the saturated and unsaturated zone. Dissertation, Technical University Berlin (in German).
29. Metcalfe C.D., Miao X.-S., Koenig B.D., and Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the Lower Great Lakes, Canada. Environ Toxicol Chem 22 12 (2003) 2881-2889
30. Meylan W.M., and Howard P.H. Bond contribution method for estimating Henry ́s Law constants. Environ Toxicol Chem 10 10 (1991) 1283-1293
31. Möhle E., Kempter C., Kern A., and Metzger J.W. Examination of the degradation of drugs in municipal sewage plants using liquid chromatography-electrospray mass spectrometry. Acta hydrochim hydrobiol 27 6 (1999) 430-436 (in German)
32. Moore D.E., Roberts-Thomson S., Zhen D., and Duke C.C. Photochemical studies on the anti-inflammatory drug diclofenac. Photochem Photobiol 52 4 (1990) 685-690
33. Müller S. Application of the ATV-water-quality-model in current water management practice. Wasser Boden 55 5 (2003) 18-21 (in German)
34. Packer J.L., Werner J.J., Latch D.E., McNeill K., and Arnold W.A. Photochemical fate of pharmaceuticals in the environment: naproxen, diclofenac, clofibric acid, and ibuprofen. Aquat Sci 65 4 (2003) 342-351
35. Poiger T., Buser H.-R., and Müller M.D. Photodegradation of the pharmaceutical drug diclofenac in a lake: pathway, field measurements, and mathematical modeling. Environ Toxicol Chem 20 2 (2001) 256-263
36. Roberts P.H., and Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356 1-3 (2006) 143-153
37. Scheytt T., Mersmann P., Lindstädt R., and Heberer T. 1-octanol/water partition coefficients of 5 pharmaceuticals from human medical care: carbamazepine, clofibric acid, diclofenac, ibuprofen, and propyphenazone. Water Air Soil Pollut 165 1-4 (2005) 3-11
38. Schwaiger J., Ferling H., Mallow U., Wintermayr H., and Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68 2 (2004) 141-150
39. Soulet B., Tauxe A., and Tarradellas J. Analysis of acidic drugs in Swiss wastewaters. Int J Environ Anal Chem 82 10 (2002) 659-667
40. Strenn B., Clara M., Gans O., and Kreuzinger N. Carbamazepine, diclofenac, ibuprofen and bezafibrate - investigations on the behaviour of selected pharmaceuticals during wastewater treatment. Water Sci Technol 50 2 (2004) 269-276
41. Stumpf M., Ternes T.A., Wilken R.-D., Rodrigues S.V., and Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225 1-2 (1999) 135-141
42. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., and Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39 9 (2005) 1761-1772
43. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32 11 (1998) 3245-3260
44. Thomas P.M., and Forster G.D. Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process. Environ Toxicol Chem 24 1 (2005) 25-30
45. Tixier C., Singer H.P., Oellers S., and Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen and naproxen in surface waters. Environ Sci Technol 37 6 (2003) 1061-1068
46. Triebskorn R., Casper H., Heyd A., Eikemper R., Köhler H.-R., and Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 68 2 (2004) 151-166
47. Wiegel S., Aulinger A., Brockmeyer R., Harms H., Löffler J., Reincke H., et al. Pharmaceutical in the River Elbe and its Tributaries. Chemosphere 57 2 (2004) 107-126
48. Zwiener C., and Frimmel F.H. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci Total Environ 309 1-3 (2003) 201-211